Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing WHO grade for brain astrocytomas-Reference-Cited by-同舟云学术

Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing WHO grade for brain astrocytomas

Published:2013-10-29 Issue:6 Volume:39 Page:1569-1574
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Wang Xiao-chun¹²,Zhang Hui¹²,Tan Yan¹²,Qin Jiang-bo¹,Wu Xiao-feng¹,Wang Le¹,Zhang Lei¹

Affiliation:

1. Department of Radiology; First Clinical Medical College; Shanxi Medical University; Taiyuan China

2. Department of Medical Imaging; Shanxi Medical University; Taiyuan China

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmri.24312/fullpdf

Reference12 articles.

1. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade;Law;AJNR Am J Neuroradiol,2004

2. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas;Law;AJNR Am J Neuroradiol,2007

3. Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma;Lupo;AJNR Am J Neuroradiol,2007

4. The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas;Hilario;AJNR Am J Neuroradiol,2012

5. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging;Park;AJNR Am J Neuroradiol,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigative Radiogenomic Analysis of Gliomas by Combining miRNA Profiles and Functional MRI;2024

2. Molecular imaging of gliomas;Clinical Neuropathology;2023-07-01

3. Magnetic resonance imaging-derived parameters to predict response to regorafenib in recurrent glioblastoma;Neuroradiology;2023-05-29

4. Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI;European Radiology;2023-05-03

5. Imaging the WHO 2021 Brain Tumor Classification: Fully Automated Analysis of Imaging Features of Newly Diagnosed Gliomas;Cancers;2023-04-18